This deregulation is marked by an increased labile iron pool (LIP), overexpression of transferrin receptors (TfRs), and altered activity of iron regulatory proteins (IRPs), particularly IRP2, which plays a pivotal role in maintaining iron homeostasis within tumor cells [91,92]. Here, IREB2 is linked to neoplasm.